Taizhou Baiying Biotechnology
PrivateLast Round
Series B
Sep 2, 2022
Total Funding Raised
$92.05M
Company Overview
Biointron is a biotechnology company specializing in recombinant antibody technology and contract research organization (CRO) services aimed at streamlining the antibody discovery process through advanced expression platforms, sequencing, and labeling tools.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Taizhou Baiying Biotechnology Comparables
Compare Taizhou Baiying Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Creative Biolabs | 85% | |
| Genovac Antibody Discovery | 82% | |
| ProteoGenix | 82% |
Taizhou Baiying Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 2, 2022 | ||||
| Series A | May 24, 2021 | ||||
| Angel | Jul 23, 2018 |
Taizhou Baiying Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jifeng Ventures | Series B |
| Haitong Bank | Series B |
| Joy Capital | Series B |
| Jiangsu Provincial Government Investment Fund | Series B |
| Furong Investment | Series A |
| ALAN Asset Management | Series B |
| Jiangsu Tianyou Investment Management | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
New platform helps drug developers identify manufacturing problems early.
- Dec 17, 2025
Received the 2025 Scientist.com Supplier Performance Recognition Award.
Recent news
Latest coverage and updates
- launchesJul 27, 2026
Biointron Biological USA Inc launched RushData platform for AI-driven antibody discovery on Jul 27th '26.
- attends_eventJul 13, 2026
Biointron attended event BIO International Convention on Jun 23rd '26.
Taizhou Baiying Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Taizhou Baiying Biotechnology's valuation, stock price, and market status.
Is Taizhou Baiying Biotechnology a public or private company?
Taizhou Baiying Biotechnology is a private company.
What is the current stock price of Taizhou Baiying Biotechnology?
Taizhou Baiying Biotechnology is a private company with no public stock price. No recent secondary market data is available.
How much is Taizhou Baiying Biotechnology worth (valuation)?
Valuation information for Taizhou Baiying Biotechnology is not publicly available.
Can I buy Taizhou Baiying Biotechnology stock?
Taizhou Baiying Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Taizhou Baiying Biotechnology's last funding round?
Taizhou Baiying Biotechnology's most recent funding round was Series B on September 2, 2022.
Who are the main investors in Taizhou Baiying Biotechnology?
Key investors in Taizhou Baiying Biotechnology include Jifeng Ventures, Haitong Bank, CoStone Capital.
Will Taizhou Baiying Biotechnology IPO soon?
No public IPO plans have been announced for Taizhou Baiying Biotechnology.
How can I track Taizhou Baiying Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Taizhou Baiying Biotechnology's secondary market activity and sign up for updates.